Search Results - xing+lu

5 Results Sort By:
y-AApeptide-based long-acting pan-coronavirus fusion inhibitor with dual targets in spike protein and oral bioavailability
­Advantages: S-20-1 demonstrates potent inhibitory action, this broad-spectrum activity suggests that S-20-1 could be effective against a wide range of coronaviruses, making it a valuable candidate for pandemic preparedness and management. The research provides insights into the mechanism of action of S-20-1, demonstrating its ability to bind...
Published: 9/25/2023   |   Inventor(s): Jianfeng Cai, Shibo JIANG, Lu LU, Songyi XUE, Xinling WANG, Lei WANG, Wei XU, Shuai XIA
Keywords(s): Drug Discovery, Immunology
Category(s): Technology Classifications > Medical > Biotechnology
Translucent Thermoplastic Polyolefin (TPO)
Executive Summary Thermoplastic polyolefins (TPO) are used in a variety of applications such as automotive bumpers and fascia where good impact and chemical resistance are needed.. MSU researchers have recently developed a new technology for producing translucent TPO materials. The materials are compounded by conventional extrusion and then molded...
Published: 2/17/2023   |   Inventor(s): Krishnamurthy Jayaraman, Xing Lu
Keywords(s):  
Category(s): Advanced Materials, Transportation
Network-Coded Multiple Access
[Licensing negotiation in progress] [Invitation for Expression of Interest - Deadline: 16 June 2016] Systems and methods include a first wireless local area network (WLAN) system that jointly exploit physical-layer network coding (PNC) and multi-user decoding (MUD) to boost system throughput. This multiple access mode is referred to as Network-Coded...
Published: 1/29/2024   |   Inventor(s): Soung Chang Liew, Lu LU, Lizhao You
Keywords(s): Network Coding, Wireless Local Area Network
Category(s): Information and Communications Technology
EGFR Inhibitors as Therapeutic Agents for Breast Cancer Bone Metastasis
Princeton University Invention # 09-2509 The involvement of the EGFR signaling pathway in bone metastasis has been implicated by a number of studies. However, the therapeutic significance by targeting EGFR signaling in the tumor-stroma interface has not been evaluated. Researchers in the Molecular Biology Department at Princeton...
Published: 3/30/2022   |   Inventor(s): Yibin Kang, Xin Lu
Keywords(s): antibody, cancer/oncology, therapeutic
Category(s): Biotechnology/Pharmaceuticals
VCAM1 and VLA4 as Therapeutic Targets for Anti-Tumor and Anti Metastatic Therapy
Princeton University Invention # 09-2550 In breast cancer patients, disseminated tumor cells from the primary site can remain in a dormant state in the secondary organ for a long period before starting to grow into life-threatening metastasis. However, the molecular understanding of this process is still very limited. Researchers in Molecular...
Published: 3/30/2022   |   Inventor(s): Yibin Kang, Xin Lu
Keywords(s):  
Category(s): Biotechnology/Pharmaceuticals